Smith & Nephew (SNN) Other Non-Current Liabilities (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Other Non-Current Liabilities of $82.0 million for Q4 2025, down 24.07% year-on-year from $108.0 million in Q4 2024, and down 12.77% on a QoQ basis from $94.0 million in Q2 2025.

Smith & Nephew (SNN) Other Non-Current Liabilities (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Other Non-Current Liabilities for 17 consecutive years, with $82.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 24.07% year-over-year to $82.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $82.0 million (down 24.07% YoY) and the FY2025 annual result came in at $82.0 million, down 24.07% from the prior year.
  • Other Non-Current Liabilities fell to $82.0 million in Q4 2025 per SNN's latest filing, from $94.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for SNN reached as high as $243.0 million in Q4 2022 and fell as low as $35.0 million in Q4 2021.
  • A 5-year average of $135.3 million and a median of $108.0 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2021 — Other Non-Current Liabilities tumbled 88.1% — and 2022, when it jumped 594.29%.
  • Year by year, Other Non-Current Liabilities stood at $35.0 million in 2021, then soared by 594.29% to $243.0 million in 2022, then dropped by 4.12% to $233.0 million in 2023, then tumbled by 53.65% to $108.0 million in 2024, then declined by 24.07% to $82.0 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $82.0 million, $94.0 million, and $108.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 82.00 Mn
Jun 28, 2025 94.00 Mn
Dec 31, 2024 108.00 Mn
Jun 29, 2024 152.00 Mn
Dec 31, 2023 233.00 Mn
Dec 31, 2022 243.00 Mn
Dec 31, 2021 35.00 Mn
Dec 31, 2020 294.00 Mn
Jun 30, 2020 236.00 Mn
Dec 31, 2019 214.00 Mn
Jun 29, 2019 143.00 Mn
Dec 31, 2018 153.00 Mn
Jun 30, 2018 137.00 Mn
Dec 31, 2017 97.00 Mn
Dec 31, 2016 134.00 Mn
Dec 31, 2015 193.00 Mn
Jun 30, 2015 79.00 Mn
Dec 31, 2014 67.00 Mn
Sep 30, 2014 83.00 Mn
Jun 28, 2014 112.00 Mn